Lipid level and risk of Alzheimer′s disease: a systematic review and meta-analysis

ObjectiveTo systematically evaluate the role of blood lipid level in predicting the risk of Alzheimer′s disease (AD). MethodsWe searched Chinese National Knowledge Infrastructure (CNKI), Wanfang Database, VIP Database for Chinese Technical Periodicals (VIP), Pubmed, Web of Science, Springer, and Coc...

Full description

Bibliographic Details
Published in:Zhongguo gonggong weisheng
Main Authors: Xuan-rui LÜ, Jing XU, Xiao-nan LIN, Jing SONG
Format: Article
Language:Chinese
Published: Editorial Office of Chinese Journal of Public Health 2022-08-01
Subjects:
Online Access:https://www.zgggws.com/article/doi/10.11847/zgggws1138716
_version_ 1849814174114250752
author Xuan-rui LÜ
Jing XU
Xiao-nan LIN
Jing SONG
author_facet Xuan-rui LÜ
Jing XU
Xiao-nan LIN
Jing SONG
author_sort Xuan-rui LÜ
collection DOAJ
container_title Zhongguo gonggong weisheng
description ObjectiveTo systematically evaluate the role of blood lipid level in predicting the risk of Alzheimer′s disease (AD). MethodsWe searched Chinese National Knowledge Infrastructure (CNKI), Wanfang Database, VIP Database for Chinese Technical Periodicals (VIP), Pubmed, Web of Science, Springer, and Cocharne Library for literatures on the correlation between AD incidence and blood lipid level published in Chinese or English till June 2021 and supplementary manual tracing for some of the references was also conducted. Newcastle-Ottawa-Scale literature quality evaluation scale was adopted to evaluate the quality of the included studies. Statistical analyses were performed with RevMan5.3 software. ResultsA total of 15 eligible studies were selected according to the inclusion and exclusion criteria, and the data on blood lipid level were collected from 1 435 healthy elderly people and 2 162 elderly people with AD. Meta-analysis showed that there was no significant difference in total cholesterol (TC) and triglyceride (TG) level between the AD sufferers and the healthy controls;low-density lipoprotein cholesterol (LDL-C) was significantly higher in the AD sufferers than that in the healthy controls (mean difference [MD] = 3.59,95% confidence interval [95% CI]: 0.98 – 6.21); while, high-density lipoprotein cholesterol (HDL-C) was significantly lower in the AD sufferers than that in the healthy controls (MD = – 3.47,95% CI: – 5.94 – – 0.99). ConclusionHigher LDL-C level but lower HDL-C level may indicate a higher risk of AD in older adults.
format Article
id doaj-art-e70de86d0c464ca48830c7d6eaa19bd7
institution Directory of Open Access Journals
issn 1001-0580
language zho
publishDate 2022-08-01
publisher Editorial Office of Chinese Journal of Public Health
record_format Article
spelling doaj-art-e70de86d0c464ca48830c7d6eaa19bd72025-08-20T01:32:54ZzhoEditorial Office of Chinese Journal of Public HealthZhongguo gonggong weisheng1001-05802022-08-013881066106910.11847/zgggws11387161138716Lipid level and risk of Alzheimer′s disease: a systematic review and meta-analysisXuan-rui LÜ0Jing XU1Xiao-nan LIN2345Jing SONG6789Research Group of Jian Gong on Pharmacoepidemiology and Clinical Drug Evaluation, Shenyang Pharmaceutical University, Shenyang, Liaoning Province 110016, ChinaResearch Group of Jian Gong on Pharmacoepidemiology and Clinical Drug Evaluation, Shenyang Pharmaceutical University, Shenyang, Liaoning Province 110016, ChinaResearch Group of Jian Gong on Pharmacoepidemiology and Clinical Drug Evaluation, Shenyang Pharmaceutical University, Shenyang, Liaoning Province 110016, ChinaResearch Group of Jian Gong on Pharmacoepidemiology and Clinical Drug Evaluation, Shenyang Pharmaceutical University, Shenyang, Liaoning Province 110016, ChinaResearch Group of Jian Gong on Pharmacoepidemiology and Clinical Drug Evaluation, Shenyang Pharmaceutical University, Shenyang, Liaoning Province 110016, ChinaResearch Group of Jian Gong on Pharmacoepidemiology and Clinical Drug Evaluation, Shenyang Pharmaceutical University, Shenyang, Liaoning Province 110016, ChinaResearch Group of Jian Gong on Pharmacoepidemiology and Clinical Drug Evaluation, Shenyang Pharmaceutical University, Shenyang, Liaoning Province 110016, ChinaResearch Group of Jian Gong on Pharmacoepidemiology and Clinical Drug Evaluation, Shenyang Pharmaceutical University, Shenyang, Liaoning Province 110016, ChinaResearch Group of Jian Gong on Pharmacoepidemiology and Clinical Drug Evaluation, Shenyang Pharmaceutical University, Shenyang, Liaoning Province 110016, ChinaResearch Group of Jian Gong on Pharmacoepidemiology and Clinical Drug Evaluation, Shenyang Pharmaceutical University, Shenyang, Liaoning Province 110016, ChinaObjectiveTo systematically evaluate the role of blood lipid level in predicting the risk of Alzheimer′s disease (AD). MethodsWe searched Chinese National Knowledge Infrastructure (CNKI), Wanfang Database, VIP Database for Chinese Technical Periodicals (VIP), Pubmed, Web of Science, Springer, and Cocharne Library for literatures on the correlation between AD incidence and blood lipid level published in Chinese or English till June 2021 and supplementary manual tracing for some of the references was also conducted. Newcastle-Ottawa-Scale literature quality evaluation scale was adopted to evaluate the quality of the included studies. Statistical analyses were performed with RevMan5.3 software. ResultsA total of 15 eligible studies were selected according to the inclusion and exclusion criteria, and the data on blood lipid level were collected from 1 435 healthy elderly people and 2 162 elderly people with AD. Meta-analysis showed that there was no significant difference in total cholesterol (TC) and triglyceride (TG) level between the AD sufferers and the healthy controls;low-density lipoprotein cholesterol (LDL-C) was significantly higher in the AD sufferers than that in the healthy controls (mean difference [MD] = 3.59,95% confidence interval [95% CI]: 0.98 – 6.21); while, high-density lipoprotein cholesterol (HDL-C) was significantly lower in the AD sufferers than that in the healthy controls (MD = – 3.47,95% CI: – 5.94 – – 0.99). ConclusionHigher LDL-C level but lower HDL-C level may indicate a higher risk of AD in older adults.https://www.zgggws.com/article/doi/10.11847/zgggws1138716alzheimer’s diseaseblood lipid levelincidence riskmeta-analysis
spellingShingle Xuan-rui LÜ
Jing XU
Xiao-nan LIN
Jing SONG
Lipid level and risk of Alzheimer′s disease: a systematic review and meta-analysis
alzheimer’s disease
blood lipid level
incidence risk
meta-analysis
title Lipid level and risk of Alzheimer′s disease: a systematic review and meta-analysis
title_full Lipid level and risk of Alzheimer′s disease: a systematic review and meta-analysis
title_fullStr Lipid level and risk of Alzheimer′s disease: a systematic review and meta-analysis
title_full_unstemmed Lipid level and risk of Alzheimer′s disease: a systematic review and meta-analysis
title_short Lipid level and risk of Alzheimer′s disease: a systematic review and meta-analysis
title_sort lipid level and risk of alzheimer s disease a systematic review and meta analysis
topic alzheimer’s disease
blood lipid level
incidence risk
meta-analysis
url https://www.zgggws.com/article/doi/10.11847/zgggws1138716
work_keys_str_mv AT xuanruilu lipidlevelandriskofalzheimersdiseaseasystematicreviewandmetaanalysis
AT jingxu lipidlevelandriskofalzheimersdiseaseasystematicreviewandmetaanalysis
AT xiaonanlin lipidlevelandriskofalzheimersdiseaseasystematicreviewandmetaanalysis
AT jingsong lipidlevelandriskofalzheimersdiseaseasystematicreviewandmetaanalysis